Stop the clots, spare the coagulation Anjali Nimesh Nimesh16 Jan 2018 7:20 PM ISTOne of the most important and fraught processes in the human body is inflammation. Inflammatory responses to injury or disease are crucial for...
Praxbind (idarucizumab)-Specific reversal agent for Dabigatran approved Medha Baranwal Baranwal24 April 2018 7:05 PM ISTPraxbind (idarucizumab), the specific reversal agent for Pradaxa (dabigatran etexilate mesylate) received full approval by the U.S. Food and Drug...
Dabigatran, Rivaroxaban, and Apixaban similarly effective in nonvalvular AF Medha Baranwal Baranwal24 July 2018 7:15 PM ISTThe risk for stroke or systemic embolism in patients with nonvalvular atrial fibrillation (AF) is not significantly different between 3 non-vitamin K...
Management of Hemostasis and Thrombosis in Liver Disease : Latest Recommendations Medha Baranwal Baranwal16 Sept 2018 7:03 PM ISTPatients with acute and chronic liver disease frequently acquire unique changes in hemodynamic and hemostatic pathways that may result in...
Guideline on use of anticoagulation and pro-coagulants in cirrhosis patients Medha Baranwal Baranwal13 July 2019 6:37 PM ISTThe American Gastroenterological Association (AGA) has released guidance on the use of currently available testing of the coagulation cascade, and...
Management of Hemophilia- Indian Academy of Pediatrics Guideline Medha Baranwal Baranwal6 Sept 2018 7:03 PM ISTThe Indian Academy of Pediatrics has released consensus guidelines for the diagnosis and management of hemophilia in India. The guideline is published...
